mTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 vaccine in kidney transplant recipients

Kidney transplant recipients (KTRs) have been considered as patients at higher risk of SARS-CoV-2-related disease severity, thus COVID-19 vaccination was highly recommended. However, possible interferences of different immunosuppression with development of both humoral and T cell–mediated immune res...

Descripción completa

Detalles Bibliográficos
Autores principales: Netti, Giuseppe S., Infante, Barbara, Troise, Dario, Mercuri, Silvia, Panico, Maddalena, Spadaccino, Federica, Catalano, Valeria, Gigante, Margherita, Simone, Simona, Pontrelli, Paola, Gesualdo, Loreto, Ranieri, Elena, Castellano, Giuseppe, Stallone, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303518/
https://www.ncbi.nlm.nih.gov/pubmed/35038362
http://dx.doi.org/10.1111/ajt.16958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303518/
https://www.ncbi.nlm.nih.gov/pubmed/35038362
http://dx.doi.org/10.1111/ajt.16958

Ejemplares similares